A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors.
Brænne I, Willenborg C, Tragante V, Kessler T, Zeng L, Reiz B, Kleinecke M, von Ameln S, Willer CJ, Laakso M, Wild PS, Zeller T, Wallentin L, Franks PW, Salomaa V, Dehghan A, Meitinger T, Samani NJ, Asselbergs FW, Erdmann J, Schunkert H.
Brænne I, et al. Among authors: kleinecke m.
Sci Rep. 2017 Aug 31;7(1):10252. doi: 10.1038/s41598-017-10928-4.
Sci Rep. 2017.
PMID: 28860667
Free PMC article.